Reduces the risk of death
This therapy is best suited for high risk covid patients within the first 10 days of onset of symptoms. It can be given to mild to moderate corona infected patients. This antibody cocktail can be given to adults and children over the age of 12, as well as to patients with mild to moderate symptoms of corona and patients who are at high risk of developing severe disease and do not require oxygen. These antibodies are helpful in reducing the risk of hospitalization and death by up to 70 percent in high-risk patients before their condition worsens.